← Leaderboards
Laila Abdullah
James A. Haley Va Medical Center
$2,970,877
Attributed
$3,451,275
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $909K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,451,275 · 6
VA$0 · 4
By mechanism
R21$1,722,251 · 4
R01$1,405,024 · 1
R03$324,000 · 1
I01$0 · 4
Top collaborators
- Fiona C. Crawford8 shared
- Corbin Bachmeier5 shared
- Nancy Grace Klimas2 shared
- Michael J Mullan2 shared
Most similar at James A. Haley Va Medical Center
Same institution · by research overlap
- Fiona C. Crawford$1,676,161
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBloodAffectInflammationChronicS DiseaseApolipoprotein ELipidsPre-ClinicalBrainAllelesLifeHigh RiskDiagnosisSymptomsGenotypeImpaired CognitionPlasmaInflammatoryExposure ToAmyloidOmega-3 Fatty AcidsOxidative StressBiological Markers
Grant awards (27)
Neurological effects of aerosolized red tide neurotoxins$700,329
R01 · FY2025 · ES · contact PI
the contribution of APOE4 mediated bioenergetic deficits in the cerebrovascular dysfunction in Alzheimer's disease$0
I01 · FY2025 · VA · contact PI
Neurological effects of aerosolized red tide neurotoxins$704,695
R01 · FY2024 · ES · contact PI
The role of adaptive immunity in organophosphate induced CNS injury$204,300
R21 · FY2024 · NS · contact PI
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease$0
I01 · FY2024 · VA · contact PI
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients$0
I01 · FY2024 · VA · contact PI
the contribution of APOE4 mediated bioenergetic deficits in the cerebrovascular dysfunction in Alzheimer's disease$0
I01 · FY2024 · VA · contact PI
Cerebrovascular contributions to APOE4-mediated brain bioenergetic deficits in Alzheimer's disease$449,460
R21 · FY2023 · AG · contact PI
The role of adaptive immunity in organophosphate induced CNS injury$244,269
R21 · FY2023 · NS · contact PI
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease$0
I01 · FY2023 · VA · contact PI
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients$0
I01 · FY2023 · VA · contact PI
The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease$162,000
R03 · FY2022 · AG · contact PI
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease$0
I01 · FY2022 · VA · contact PI
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients$0
I01 · FY2022 · VA · contact PI
Long term assessment of neurological effects after red tide exposure$190,100
R21 · FY2021 · ES · contact PI
The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease$162,000
R03 · FY2021 · AG · contact PI
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients$0
I01 · FY2021 · VA · contact PI
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease$0
I01 · FY2021 · VA · contact PI
Long term assessment of neurological effects after red tide exposure$224,400
R21 · FY2020 · ES · contact PI
Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome.$197,454
R21 · FY2020 · AI · contact PI
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients$0
I01 · FY2020 · VA · contact PI
Influence of APOE genotypes on blood brain barrier transport of DHA by mfsd2a in Alzheimer's Disease$0
I01 · FY2020 · VA · contact PI
Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome.$212,268
R21 · FY2019 · AI · contact PI
Identifying APOE related lipid biomarkers for diagnosing chronic neurocognitive deficits in TBI patients$0
I01 · FY2019 · VA · contact PI
Treating GWI immune and metabolic disturbances by targeting lipid metabolism$0
I01 · FY2019 · VA · contact PI
Treating GWI immune and metabolic disturbances by targeting lipid metabolism$0
I01 · FY2018 · VA · contact PI
Treating GWI immune and metabolic disturbances by targeting lipid metabolism$0
I01 · FY2017 · VA · contact PI